- Investing Ideas
- /
- Brazilian Pharmaceuticals & Biotech Undervalued based on future growth
Brazilian Pharmaceuticals & Biotech Undervalued based on future growth
Results
2
0 new
Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)
2 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
HYPE3 | R$18.03 | -0.1% | -49.6% | R$11.5b | R$30.91 | PE7.3x | E14.0% | 6.8% | ||
BLAU3 | R$12.68 | -9.8% | -22.7% | R$2.3b | R$17.75 | PE12x | E18.2% | 5.9% |
Page 1 of 1